Interaction of aminoadamantane derivatives with the influenza A virus M2 channel-Docking using a pore blocking model

Bioorganic & Medicinal Chemistry Letters
2010.0

Abstract

Interaction of aminoadamantanes with the influenza A virus M2 proton channel was analyzed by docking simulations of a series of synthetic aminoadamantane derivatives, of differing binding affinity, into the crystal structure of the transmembrane (M2TM) pore. The pore blocking model tested in the 'gas phase' describes qualitatively the changes on the relative binding affinities of the compounds (although a series of highly hydrophobic ligands which seem to have little capacity for different specific interactions with their receptor). The docking calculations predicted poses in which the adamantane ring is surrounded mainly by the alkyl side chains of Val27 or Ala30 and the ligand's amino group is generally hydrogen bonded with hydroxyls of Ser31 or carbonyls of Val27 or carbonyls of Ala30, the former (Ser31) being the most stable and most frequently observed. The binding of the ligand is a compromise between hydrogen bonding ability, which is elevated by a primary amino group, and apolar interactions, which are increased by the ability of the lipophilic moiety to adequately fill a hydrophobic pocket within the M2TM pore. A delicate balance of these hydrophobic contributions is required for optimal interaction.

Knowledge Graph

Similar Paper

Interaction of aminoadamantane derivatives with the influenza A virus M2 channel-Docking using a pore blocking model
Bioorganic & Medicinal Chemistry Letters 2010.0
Binding and Proton Blockage by Amantadine Variants of the Influenza M2<sub>WT</sub> and M2<sub>S31N</sub> Explained
Journal of Medicinal Chemistry 2017.0
Unraveling the Binding, Proton Blockage, and Inhibition of Influenza M2 WT and S31N by Rimantadine Variants
ACS Medicinal Chemistry Letters 2018.0
Exploring the Size Limit of Templates for Inhibitors of the M2 Ion Channel of Influenza A Virus
Journal of Medicinal Chemistry 2011.0
Aminoadamantanes with Persistent in Vitro Efficacy against H1N1 (2009) Influenza A
Journal of Medicinal Chemistry 2014.0
Identification of camphor derivatives as novel M2 ion channel inhibitors of influenza A virus
MedChemComm 2015.0
Easily Accessible Polycyclic Amines that Inhibit the Wild-Type and Amantadine-Resistant Mutants of the M2 Channel of Influenza A Virus
Journal of Medicinal Chemistry 2014.0
Synthesis and Antiviral Activity Evaluation of Some New Aminoadamantane Derivatives. 2
Journal of Medicinal Chemistry 1996.0
Novel 3-(2-Adamantyl)pyrrolidines with potent activity against influenza A virus—identification of aminoadamantane derivatives bearing two pharmacophoric amine groups
Bioorganic &amp; Medicinal Chemistry Letters 2001.0
New polycyclic dual inhibitors of the wild type and the V27A mutant M2 channel of the influenza A virus with unexpected binding mode
European Journal of Medicinal Chemistry 2015.0